ING Knock-Out VLK/ DE000NG8NPL7 /
12/20/2024 7:26:16 PM | Chg.-0.040 | Bid9:38:56 PM | Ask9:38:56 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.510EUR | -2.58% | 1.500 Bid Size: 2,000 |
1.620 Ask Size: 2,000 |
Van Lanschot Kempen ... | 27.5665 EUR | 12/31/2078 | Call |
GlobeNewswire
6/26
Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary share...
GlobeNewswire
6/25
Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900...
GlobeNewswire
6/25
Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 90...
GlobeNewswire
3/4
Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences
GlobeNewswire
2/29
MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and...
GlobeNewswire
12/22/2023
Zealand Pharma enters into EUR 90 million finance agreement with the European Investment Bank
GlobeNewswire
10/10/2023
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
GlobeNewswire
6/26/2020
Hyloris Pharmaceuticals Raises approximately EUR 61.81 million in Successful Initial Public Offering
GlobeNewswire
6/24/2020
Hyloris Pharmaceuticals Announces Narrowing of Price Range of its Initial Public Offering
GlobeNewswire
6/19/2020
Hyloris Pharmaceuticals Announces Coverage of the Maximum Offering Size, including Increase Option a...
GlobeNewswire
6/18/2020
Hyloris Pharmaceuticals Announces the Coverage of the Base Offering Throughout the Price Range of it...
GlobeNewswire
6/17/2020
Hyloris Pharmaceuticals launches its Initial Public Offering on Euronext Brussels